Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
28 Cards in this Set
- Front
- Back
AML is ___. it is defined by presence of at least ___% ___s in ___. the normal value is <___%.
|
acute myeloid leukemia
20 myeloid progenitors BM 5 |
|
2 AML scenarios
|
de novo
secondary to leukemogenic trigger |
|
AML is associated with ___ age
|
old
|
|
in AML proliferation of cells in BM causes
|
bone pain
|
|
accumulation of blasts in PB causes __ (3)
|
microangiopathy
CNS symptoms V/Q mismatch |
|
accumulation of blasts outside BM is called ___. in AML these occur in ___ (4).
|
chloroma
CNS gingiva kidney skin |
|
symptoms of AML
|
DIC
hyperuricemia tumor lysis syndrome |
|
tumor lysis syndrome symptoms
|
hyperkalemia or hypokalemia
lactic acidosis |
|
___ are pathognomonic for AML. they are composed of ___.
|
Auer rods
aggregated granules |
|
___ is a subtype of AML. it is characterized by ___ (2).
|
acute promyelocytic leukemia
hypergranulated cells Auer rods |
|
acute promyelocytic leukemia cells are more/less differentiated than plain AML cells
|
more
|
|
___% of blasts staining positive for ___ is a positive test for AML
|
3
MPO |
|
TdT is ___. it does ___ in ___ (2) cells.
|
terminal deoxynucleotidyl transferase
random nucleotide insertion at end of receptor recombination B T |
|
ALL cells are positive for ___ and negative for ___.
|
TdT
MPO |
|
AML cells are positive for ___ and negative for ___.
|
MPO
TdT |
|
a karyotype showing ___ is diagnostic of AML even if ___ is absent. another abnormality is with a favorable prognosis is ___
|
15-17 translocation
BM signs 8-21 translocation |
|
with advancing age, ___ mutations decline and ___ mutations rise.
|
favorable
unfavorable |
|
____ cases typically have ___ karyotypes and worse prognosis
|
secondary AML
elderly patients complex |
|
complex karyotype means
|
>3 abnormalities
|
|
most patients have ___ karyotype
|
normal
|
|
supportive care for acute leukemia includes __ (4)
|
hydration
allopurinol cytopheresis blood products |
|
3 tx options for AML pts under 60
|
intensive chemo
allogeneic SC transplant autologous SC transplant |
|
when cytogenetics are unfavorable use ___.
|
allogeneic SC transplant
|
|
___ (2) should have an autologous SC transplant
|
pts with favorable risk factors
pts who relapsed, responded to chemo with no matched donor |
|
AML has a ___ prognosis in pts > 60 y.o
|
very poor
|
|
ATRA is ___. it is indicated for ___ (2).
|
all trans retinoic acid
APL t(15;17) AML |
|
ALL is ___. it presents with ___ (4). T cell type can also have ___.
|
acute lymphoblastic leukemia
lymphadenopathy hepatosplenomegaly testis involvement CNS involvment mediastinal enlargement |
|
___ is an important cytogenetic marker for ALL.
|
t(9;22) philadelphia
|